CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer

Xinhui Wang(Duke Medical Center), Soldano Ferrone(Harvard University)

JNCI Journal of the National Cancer Institute

September 18, 2010

10.1093/jnci/djq343

Cited by 187

Related Papers

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma

|Frontiers in Neuroscience|2021|144

Functional Characterization of an scFv-Fc Antibody that Immunotherapeutically Targets the Common Cancer Cell Surface Proteoglycan CSPG4

|Cancer Research|2011|57

Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP

|Oncotarget|2017|18

Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells

|Research Square|2023|2